Theralase Technologies Inc. V.TLT

Financial Advisor

[Camphikefish]

While we wait. I had a brief conference with my investment advisor today and he questioned why I'd be invested in a biotech penny stock for over 10 years when my money could've tripled in the overall market. Of course I mentioned our unique science, efficacy, patient population, BTD, and the whole 9 yards as we say in the states. He briefly made me feel as if I must be financially immature, poorly informed, and misguided. There is no overall point here I'm mostly just sharing the empty pit I felt in my stomach for a minute. I wonder if any of you have felt the same? I told him we'd see who has the last laugh. Hopefully I've not been living in fantasyland for over a decade! I still believe we get to at least $5-10 eventually. Getting older! Let's go 1433 and take us to the finish line!

[Galaxym31]

I feel it . Big money , big government are not bying this story .

[anabelsi]

I feel the same way, I often think about the other opportunities that I could have invested in instead of TLT... I hope that we finally see the light at the end of the tunnel soon and have our patience rewarded. Frankly, while I am very happy with the science overall, I am quite frustrated with management at this point, the SP should absolutely not be this low with our results!

[Longholder99]

He's right...unless TLT.V goes 100 or 200x.  Your advisor probably bought a few thousand shares the next day.  

[CAinPlap]

Did you ask your advisor to show how he was able to triple his client's money over those 10 years? Did the investment company he works for see its portfolio under management triple? I'm guessing no. 

[N0taP00p]

I think we can all relate to that feeling, Camp. Sometimes, we invest based on an Initial conviction and then double down based on a combination of emotional attachment, hope and company statements that implied success is just around the corner.  Till it wasn't and we saw more delays and dilution. I thought Q1 of this year was going to to be our time, till it became Q1 of next year. I'

[CAinPlap]

I think the reason we are not yet thinking of using prior to patients being treated with BCG is that we would require an expensive phase 3 trial to compare our treatment to treating with BCG. Our current trial does not require a phase 3 as there is no standard to compare against.

[N0taP00p]

CAinPlap: I was thinking about the FDAs Frontrunner program where a promising therapy could be potentially used upstream of where the trials are focused, in our case, post-BCG today.  I don't know if that program has been successfully used anywhere. Yes, it could mean a separate set of phases. Don't know enough about it. 

[99942Apophis]

Camphikefish,  I have encountered a handful of those so called "financial advisors " believe me when I tell you they generally poorly knowledgeable of stocks, options (call&puts) chart reading related to what stage a company is in regarding its objectives.   Financial advisors interest is solely on convincing a gullible and uneducated person into becoming their client

[Camphikefish]

Thank you Apop! I needed that today. It's been a long hard road. Still hope to meet you all one day in Vegas. Godspeed everyone

[FGPstock]

  Cfish, your advisor is probably right. His job is to give you a decent return on investment w proven companies so u can sleep at night, not put u in 10x or 100x plays as more fail than succeed. I think a lot of us, myself included, have bought more shares and are overweighted in Tlt. Sometimes I wonder how many years this has taken off my life as we are always waiting for "next year

[CAinPlap]

Yes we'd all be rich if we had that crystal ball. I mean how could we have predicted how Covid would have benefited the worlds billionaires so much. ;)    I'm more inclined to take Apop's view on investment advisors. They are mostly interested in how they can transfer your wealth to their income statement.  

[skier59]

This is so true, and exactly my feelings, and more !

[Pandora]

Annual Information Form has just been posted on Sedar.

[Yajne]

Thanks, now Sedar is a place I haven't been for awhile, ever since they made wholesale changes and my initial attempts to maneuver through it were unsuccessful. Haven't had the desire to try again, but this gives me good reason to I guess. Anybody with 'tips' to simplify the new SEDAR?

[gebremeskel]

All you gotta do is go to  https://www.sedarplus.ca/ and click on SearchSEDAR+ and then type 'Theralase' in profile name or number - you can then click on the Theralase Technologies Inc. popup - and then set the From date and To date, then click on the Search button, you should then get the news releases between the two dates.

[GrahamB]

Financial advisors tend to be a conservative lot, and because penny stocks have significant risks  as they are story stocks. Sure, they could double, go 10x or more. The problem is they usually dont and are considered highly speculative, volatile, less liquid and the companies are usually unproven companies, and may have less rigorous reporting standards.  FWIW I did do a quick dive on

[Oilminerdeluxe]

Well, I don't think a single soul here is invested because of the financials...

[BlueFranky]

OMD - In a word.. baiting.

[Benedictus]

While I agree the financials are an ongoing concern and we will very likely need funds from either an additional share issuance or, dare we hope, a regional partner announcement, I disagree with your comment that "directionally, the opportunity cost at this point certainly favors the advisor". At this advanced stage, I would argue this is an asymmetric opportunity for a better treatment

[GrahamB]

All good points. And I hear you. Looking forward, you may see catalysts, and positive price action, which can affect how you consider the future, but from my understanding the investment advisor was talking about the past 10 years return compared to being into TLT.   My comment was that he was directionally right. By this I mean I wasn’t there, and I don’t know which index he was referring

[Legit62]

GrahamB why are you here if you are not an investor, who paid you for your comments?? If you are so smart you should be working on Wall Street and not worrying about a penny stock on a Canadian exhange,very interesting

[GrahamB]

Hi Legit. Unfortunately no pay check for writing her-just enjoy sharing thoughts and hearing others analysis-especially four underfollowed small caps. They call it work for a reason.! Ha ha I am FI for a while and just do what I want now. I enjoy trying to solve puzzles-thats what these small caps are. For example, here the finacials are as stated-concerning. The story while r interesting hasn'

[Oilminerdeluxe]

Ok, Graham. I will take the bait. What do you mean when you say the story isn't proven? Do you suggest that the people that are cancer free after 15 months are NOT cancer free at 15 months and beyond? Because, THEY ARE!

[skys1]

Great posts legit, steven, & oilminerdelux. Don't fall for GrahamB's BS. It is obvious. He is here for a reason. He says he is done, but keeps making posts, he says he has no interest but he will be back on news. He makes these long drawn out posts with all kinds of market ststatistics that take a great deal of time to assemble, even though he has "no skin in the game?" As I

[Legit62]

Right on Skys1

[GrahamB]

Thanks for your thoughts oilminer-appreciate learning more about the molecule and great to hear your enthusiasm. My basis for saying  the story (Ruvidar ) is unproven at this point, comes directly from they companies data.   For the most recent data, that I have seen, correct me if you have more recent data, the Phase II NMIBC Clinical Study, the primary objective is: “In

[Longholder99]

Most here put soft and not so soft bashers on ignore pretty quick so I doubt you will be missed.

[Benedictus]

Graham, while I appreciate your thorough posts here, the recent MD&A is the more suitable up to date resource to use as a reference. The results have improved to 13 CR in 39 patients (33%), with the optimized cohort at 10 CR in 29 patients (34%). Yes, this is preliminary data but it is far stronger than the approved options for patients. We also must keep in mind there is a real urgency to

[DJDawg]

To put a statistical spin on thing. The FDA approves things not based on the %CR but based on the statistics for that data presented. If you think about a company with a drug that has a 40% respsonse in the first 10 patients treated. That 40% response translates into a true response that could be anywhere from 10-70%. Imagine you have a massive jar of jelly beans and  you pull 10 out

[GrahamB]

Thanks for your thoughts. I have a fair bit of experience reviewing FDA decsions based on research with other molecules. The statistics reported are one aspect, but there are many more, including risk/benefit, alternatives, prior discussions with the company and agreements re outcome metrics, and the track chosen. There are also soft factors, IMO, such as the experience and ability to communicate

[DJDawg]

Fair points. For the safety signal, the safety data seems generally good for the number treated and given that it is a bladder instillation drug (rather than systemic) the true safety is likely to be reasonable compared to something intravenous. Did you refer the most recent Swimmers plot? I find that a good visual. One thing that led many of us here was the phase 1 b data. Are you familiar

[GrahamB]

All good points Dawg. I get why you are in.  I did look at the other data you referenced. take care!

[StevenBirch]

You are right Dawg. It's like Trading Places when Dan Ackroyd wants to pawn his watch and goes on and on about why it is worth thousands and Bo Diddley tells him "in Philadelphia it's worth 50 bucks". We are in Philadelphia right now and no one will pay more than '50 bucks' until it is FDA approved. The cheerleaders understand this and the naysayers whether they

[Rumpl3StiltSkin]

Graham, The only things I look at, as a long term holder of TLT, is what is the likelihood of BTD? With quite a few folk running around with intact bladders... BTD seems solid. So does a jv shortly after as it makes sence for a partner to get in before AA. IMO

[N0taP00p]

@GrahamB:  After nearly two years of working with the FDA as a fast track designee and presenting at various peer conferences,  the risk of using a different imputation method (as a totally unexpected surprise) is very low.  TLT seems to be presenting the data in the same way other companies did. I only worry about them sticking to stated milestones. It's been a long trip on

[Longholder99]

You folks know this poster is just having fun with you....don't you?  The more you respond ....you feed it.  I used the ignore function to quiet the noise.  Just saying.

[BudFoxx2020]

But what do you mean GrahamB.  TLT science are validated by the best doctors and scholars in the world, the doctors on the TLT StockHouse board.   Lololololol.  Here is my advice, don't bother.  You will only get attacked and chased off the board.   I also have this stock on my watchlist since 2010 when they announced they are on the verge of Cancer cure and

[Lesalpes29]

Bud you are f... dummy. 

[99942Apophis]

GrahamB, thank you for validating my point. Your point of view can only be applied to a fundamental revenue generating company and although currently the cold Lazar division is pulling in some money the bulk portion will come from TLT Cancer treatment. As said thank you for validating my point in the fact your approach which is the same as an Advisor only focuses on fundamentals rather than a

[StevenBirch]

Graham B Gone. Same for this fictional 'financial advisor'. And the people who claim to have mentioned TLT to their doctor who treats them for toe fungus or the common cold and gotten a lukewarm response because why WOULD he know about TLT? Any talk of TLT and ANY index over the last 10 years is ludicrous and either shows an ignorance about investing or ulterior motives.

[GrahamB]

Interesting point of view for sure Steven. To each his/her/thier own. I think from the conversation we were discussing the opportunity cost of investing for ten years in TLT vs other equities. I suppose you could look at other asset classes-even the Russel or small cap index, or other companies. I think its fair to talk about opportunity cost and see it differently than you. After all, one of

[Boomer51]

Steven I know this jerk froM( HUGE) cannabis a few years ago where I got soaked pretty good .He's a mister know it all who knows nothing.

[GrahamB]

Hi Boomer. If you knew me, you would know that there are indeed many things I know nothing about! However, I did call HUGE correctly from the beginning which is a matter of record in my post history.  Sorry for your losses on HUGE, by the way. If you back and look at the posts, I did note from the outset, the stock had serious issues, and that it had financial and operational issues. All

[StevenBirch]

So he's an easy ignore then.

[Camphikefish]

What a joke. I met with my financial advisor because I just flipped all of my 401k investments from leaving a company after 20 years. There's nothing fictional about it. I realize commenting on a post like yours is a waste of time however, check your arrogance at the door brother. I spoke the truth and it was only conversation because we are all out here waiting for BTD. I mean you no harm but

[GrahamB]

Hi Camphike Not sure if this referencing my post, but I hope you didnt think I meant it was a fictional. I didnt . I just wasn't there so knowing how and when to base the returns on wasn't possible. I thought it was a great post and interesting Sorry if you took that from my post-certainly not intended  I would send you a virtual beer if possible! Peace

[Camphikefish]

Hi GB, that was not meant for you at all. Should've kept my mouth shut anyway. Some folks here are a bit abrasive and think they know everything. They certainly do not and I should know to let it ride. Thank you for your input. All the best to you!